Cargando…
OR16-05 25-Hydroxycholesterol Mediates The Effects Of Dyslipidemia On Triple Negative Breast Cancer Metastasis
Disclosure: A. Etella: None. T. Scully: None. S. Jordan: None. C. Kang: None. M.G. Jeffrey: None. N.G. Kase: None. D. LeRoith: None. E.J. Gallagher: Advisory Board Member; Self; Novartis Pharmaceuticals. Consulting Fee; Self; Seagen, Flare Therapeutics. Excess body weight and dyslipdemia have been a...
Autores principales: | Etella, Abora, Scully, Tiffany, Jordan, Stefan, Kang, Chifei, Jeffrey, McDonald G, Kase, Nathan G, LeRoith, Derek, Gallagher, Emily J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10554948/ http://dx.doi.org/10.1210/jendso/bvad114.2197 |
Ejemplares similares
-
SUN-131 The Roles of Two Insulin Receptor Isoforms in Triple Negative Breast Cancer Growth
por: Kang, Chifei, et al.
Publicado: (2020) -
SAT-151 Regulation of Low-Density Lipoprotein Receptor Expression in Triple Negative Breast Cancer
por: Scully, Tiffany, et al.
Publicado: (2020) -
SAT-137 The Effect of Hypertriglyceridemia on Triple Negative Breast Cancer Progression
por: Scully, Tiffany, et al.
Publicado: (2020) -
Obesity, Type 2 Diabetes, and Cancer Risk
por: Scully, Tiffany, et al.
Publicado: (2021) -
Regulation of low-density lipoprotein receptor expression in triple negative breast cancer by EGFR-MAPK signaling
por: Scully, Tiffany, et al.
Publicado: (2021)